Dicyclomine Hydrochloride
Product Images NDC 67296-0514

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dicyclomine Hydrochloride (NDC 67296-0514). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dicyclomine Hydrochloride Structural Formula (Image 1)

FDA Label Image

New (Image 2)

New (Image 2)
This is a description of Dicyclomine Hydrochloride Capsules, USP with NDC number 0591-0794-01. Each capsule contains 10 mg of Dicyclomine hydrochloride USP. The recommended dosage information can be found on the package outsert. These capsules are to be stored at 20°-25°C (68°-77°F) and kept out of reach of children. Manufactured by Teva Pharmaceuticals USA, Inc.*
FDA Label Image

New (Image 3)

New (Image 3)
This is a description of Dicyclomine Hydrochloride Tablets, USP, containing 20 mg of Dicyclomine hydrochloride per tablet. It is a prescription medication by Teva Pharmaceuticals USA, Inc. The usual dosage information can be found in the package insert. The tablets should be stored at 20°-25°C (68°-77°F) and kept out of reach of children. The manufacturing date of the tablets is listed as November 2020.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.